John G. Saia's Net Worth
$1.35 Million
Who is John G. Saia?
John G. Saia has an estimated net worth of $1.35 Million. This is based on reported shares across multiple companies, which include Guardant Health, Inc., ACELRX PHARMACEUTICALS INC, and WAGEWORKS, INC..
SEC CIK
John G. Saia's CIK is 0001737840
Past Insider Trading and Trends
2023 was John G. Saia's most active year for acquiring shares with 10 total transactions. John G. Saia's most active month to acquire stocks was the month of May. 2024 was John G. Saia's most active year for disposing of shares, totalling 17 transactions. John G. Saia's most active month to dispose stocks was the month of March. 2018 saw John G. Saia paying a total of $0.00 for 145,000 shares, this is the most they've acquired in one year. In 2021 John G. Saia cashed out on 1,510 shares for a total of $228,116.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Guardant Health, Inc. (GH) Snapshot price: $24
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.75% | 502 |
$26.79 | -$13,850.43 | 29.23K |
Sep 15
| |||
Form 4
| -1.52% | -443.00 |
$23.77 | -$10,530.11 | 28.73K |
Sep 9
| |||
Form 4
| +0.44% | 129 |
$28.58 | -$3,829.72 | 29.17K |
Sep 1
| |||
Form 4
| +2.20% | 626 |
$28.26 | -$9,834.48 | 29.04K |
Jul 1
| |||
Form 4
| +10.00% | 2.58K |
$30.21 | -$43,321.14 | 28.42K |
Jun 15
| |||
Form 4
| +0.66% | 169 |
$27.10 | -$2,547.40 | 25.83K |
Jun 1
| |||
Form 4
| +17.17% | 3.76K |
$17.06 | -$64,981.54 | 25.66K |
Apr 15
| |||
Form 4
| +2.69% | 574 |
$20.25 | -$8,100.00 | 21.91K |
Apr 1
| |||
Form 4
| +0.73% | 155 |
$18.97 | -$2,048.76 | 21.33K |
Mar 1
| |||
Form 4
| +2.79% | 574 |
$27.05 | -$10,820.00 | 21.18K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
| +0.64% | 132 |
$26.33 | -$3,449.23 | 20.6K |
Dec 1
| |||
Form 4
| +14.22% | 2.55K |
$29.64 | -$39,925.08 | 20.47K |
Oct 1
| |||
Form 4
| -1.66% | -302.00 |
$33.72 | -$10,183.44 | 17.92K |
Sep 9
| |||
Form 4
| +0.95% | 172 |
$35.01 | -$3,185.91 | 18.22K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +0.96% | 172 |
$31.39 | -$2,856.49 | 18.05K |
Jun 1
| |||
Form 4
| +27.68% | 3.88K |
$24.50 | -$90,454.00 | 17.88K |
Apr 15
| |||
Form 4
| +1.12% | 155 |
$29.36 | -$3,170.88 | 14K |
Mar 1
| |||
Form 4
| +1.26% | 172 |
$52.41 | -$4,769.31 | 13.85K |
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
| +2.90% | 386 |
$53.70 | -$35,764.04 | 13.68K |
Sep 1 - Sep 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
Form 4
| -7.66% | -1.10K |
$71.99 | -$79,332.98 | 13.29K |
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| -2.92% | -433.00 |
$130.85 | -$56,658.05 | 14.39K |
Sep 9
| |||
Form 4
| -6.77% | -1.08K |
$159.20 | -$171,458.40 | 14.83K |
Apr 15
| |||
Form 4
| +28.13% | 3.49K |
—
|
—
| 15.9K |
Sep 11
| |||
Form 4
|
∞
| 12.41K |
—
|
—
| 12.41K |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACELRX PHARMACEUTICALS INC (ACRX) No price found
General Counsel and Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
WAGEWORKS, INC. No price found
SVP, GC & Corporate Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||